THE PORTUGUESE NATIONAL PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE
|
|
- Ashley Smith
- 5 years ago
- Views:
Transcription
1 THE PORTUGUESE NATIONAL PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE José Artur Paiva Director of Emergency and Intensive Care Department Hospital São João Porto Associate Professor of Medicine University of Porto Infection and Sepsis I&D Group Coordinator for the National Program on Prevention of Antimicrobial Resistance Directorate National of Health- DGS Portugal
2 THE PORTUGUESE PROGRAM RESISTANT FOR THE MICRORGANISMS PREVENTION OF ANTIMICROBIAL HOW BIG IS THE RESISTANCE PROBLEM? Penicillin Man: Alexander Fleming and the Antibiotic Revolution by Kevin Brown Sir Alexander Fleming Born: 6 August 1881 Deceased: 11 March 1955 Discovery of penicillin from Penicillium notatum: 1928 Nobel Prize: 1945
3 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE Idade Mean life expectancy in Portugal Mulher Homem
4 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE The XXth century: The century of the antibiotic 1947: first report of penicillin resistant strains increasing resistance of bacteria > 70% of bacteria causing HAI are resistant 1 antibiotic usually used to treat them
5 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE Antimicrobial drug resistance in Europe Europe, %, 2005 Trends, Maximum Minimum Increase Decrease (country) (country) fd (p<0.05) (p<0.05) PNSP 36 (FR) 1.3 (NL) 27.7 BG ES, UK FQRE 29 (PT) 3 (IS) 9.7 AT, BE, BG, CZ, DE, ES, FI, HR, HU, LU, NL, PT, SE
6 RESISTANT MICRORGANISMS HOW BIG IS THE PROBLEM? ESKAPE pathogens: Enterococcus vancomycin resistant Staph. aureus meticillin resistant Klebsiella ESBL+ Acinetobacter IMIP-R Pseudomonas aeruginosa IMIP-R Enterobacter CEF-R Rice J. Infection 2008; 197:
7 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE EARS-Net 2010 Methicillin R Staphylococcus aureus
8 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE EARS-Net 2010 Vancomycin R Enterococcus faecium
9 EARS-Net 2010 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE Klebsiella pneumoniae 3rd gen. cephalosporin EARSS 2008
10 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE EARS-Net 2010 Quinolone resistant Escherichia coli Portugal Ano Resistência % %
11 EARS-Net 2010 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE Carbapenem R Klebsiella pneumoniae
12 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE EARS-Net 2010 Pseudomonas aeruginosa R to carbapenems
13 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE Occurrence of fluoroquinolone-resistant Escherichia coli (FQRE) plotted against outpatient use of fluoroquinolone antimicrobial agents in 17 European countries
14 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE Outpatient Antibiotic Consumption Trend in Europe
15 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE ESAC 2008 Outpatient antibiotic use DDD / 1000 habitants / day
16 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE Outpatient antibiotic consumption in Portugal DDD DDD ESAC
17 THE PORTUGUESE NATIONAL PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE We have a problem! A worldwide one But at a high grade No sustained improvement
18 THE PORTUGUESE NATIONAL PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE Process indicator: to decrease antibiotic consumption - quinolones by 10% - 3rd gen cephalosporins by 5% - carbapenems by 5% until 2015 Outcome indicator to decrease antimicrobial resistance
19 THE PORTUGUESE NATIONAL PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE Surveillance systems Outpatient antimicrobial consumption surveillance system Hospital antimicrobial consumption surveillance system Veterinary medicine antimicrobial consumption surveillance system Antimicrobial resistance surveillance system Antimicrobial resistance surveillance system for alert microrganisms (quick response)
20 Alert microrganisms Unfrequent pattern of resistance and that need immediate infection control measures, namely: VISA and VRSA Staphylococcus aureus resistente to linezolide; Staphylococcus. aureus and Enterococcus spp. resistent to daptomicine; Enterococcus faecium and Enterococcus faecalis resistent to vancomycin, in health units with prevalence below 5%; Enterobacteriaceae resistent to carbapenems or presumably carbapenemase producers; Pseudomonas aeruginosa pan-resistent (PDR) Pseudomonas aeruginosa extensive resistant(xdr), in health units with prevalence below 5%; Acinetobacter baumannii resistent to carbapenems, in health units with prevalence below 5%; ; Acinetobacter baumannii PDR
21 Antibiotic Use and Infection Control DeLisle S. et al. Chest 2003;123:504S-518S
22 THE PORTUGUESE NATIONAL PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE Reduce antibiotic consumption Education Guidelines Regulation and Stewardship Antimicrobial Committees and Stewards Education / Campaign Role perception Risk perception Clinician Citizen
23 THE PORTUGUESE NATIONAL PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE Guidelines a. General principles of antibiotic therapy b. Treatment of urinary tract infections c. Ampicillin e amoxicillin versus amoxicillin/clavulanate d. Surgical site infections prophylaxis e. Carbapenems use f. Quinolones use g. Carbapenem resistant Enterobacteriaceae: prevention and assessment h. Treatment of comunity acquired pneumonia PNPRA
24 Antibiotic Committees and Stwardship Role and goals standardization Empowerment THE PORTUGUESE NATIONAL PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE Extension to Primary Care and Continued Care Easy access to and use of surveillance data Education and Stewardship Synergism between Antibiotic and Infection Control Committees Close relationship with the DNH and the program head
25 Campaign for the Citizen Preserve the Antibiotics GRUPO DE INFECÇÃO E SÉPSIS From the 28th September 2011 to the 29th February 2012
26 Increase society s awareness on the serious consequences of the inadequate use of antibiotics Increase knowlwdge on microrganisms and antibiotics Change attitudes and behavior Campaign for the Citizen Goals Avoid self-medication of antibiotics Promote compliance to prescription Promote rules on how to deal with spare pills Involve doctors, nurses, phaarmaceuticals and citizens in the same goal and purpose
27 Campaign: Supporting Partners
28 Campaign: MUPIs 200 MUPIs placarded in the main cities
29 Campaign: Flyers and Posters flyers and posters
30 Campanha: Spots
31 Campaign: Results 226 insertions / news 41 press 24 TV 20 radio 141 internet
32 Meeting people actions
33 THE PORTUGUESE PROGRAM FOR THE PREVENTION OF ANTIMICROBIAL RESISTANCE Antimicrobial use: a broader problem! Humans: 50% - Hospital: 20% - Community: 80% Agriculture: 50% - Therapy; 20% - Prophylaxis: 80% - Highly questionable: 20-50% - Innapropriate use: up to 50% - Highly questionable: 40-80%
34 Portuguese Intersectorial Alliance for the Preservation of the Antibiotic Instituto Nacional de Saúde Dr. Ricardo Jorge Direcção Geral de Veterinária Direcção Geral de Inovação e Desenvolvimento Curricular DECO Associação Nacional de Farmácias Associação Portuguesa de Indústria Farmacêutica Ordem dos Médicos Ordem dos Enfermeiros Ordem dos Farmacêuticos Ordem dos Médicos Veterinários Associação Portuguesa de Médicos de Clínica Geral Administrações Regionais de Saúde Secretarias Regionais de Saúde GRUPO DE INFECÇÃO ESEPSIS
35 Portuguese Intersectorial Alliance for the Preservation of the Antibiotic
36 Alliance Memorandum 1. Recognition that the antibiotic is endangered and needs to be protected, as it is an unique medication producing potential individual benefit but individual and colective risk; 2. Eviction of self-medication, promotion of compliance to medical prescription and of the pharmacist role as a pedagogue in antibiotic use;
37 Alliance Memorandum 3. Consolidation of the infection control activity and MDRMo cross transmission prevention, both in the community and in the hospital, namely promoting biosafety and vaccination in human and veterinary medicine; 4. Promotion of investigation on epidemiology and antimicrobial resistance, in human and veterinary sectors and of an easy access of clinicians to data on antibiotic consumption and prevalence and susceptibility of microrganisms;
38 Alliance Memorandum 5. Emanation and implementation of guidelines on the use of antibiotics in human and veterinary medicine; 6. Implementation of stuctures and processes of antibiotic stewardship in all health units, including primary and continued care, as stated in DGS 028/2011 of 15/07/2011; 7. Development of the use of rapid microbiological tests, that will permit decrease the avoidable use of antibiotics;
39 Alliance Memorandum 8. Implementation of rewardin policy for health units that attain good results, decreasing antibiotic consumption and antimicrobial resistance; 9. Promotion of a swift investigation, development and marketing of new, innovative and useful antibiotics 10. Promotion of the practices put forward by the European Platform for the Respondsible Use of Medication in Animals (EPRUMA).
40 World Alliance Against Multiresistant Organisms 3-4 Feb 2012
41 Contest for the 2nd and 3rd cycle Direcção Geral de Inovação e Desenvolvimento Curricular Direcção Geral da Saúde Grupo de Infecção e Sepsis Children and adollescents as vector of a chain of andragogy Enhance e-bug
42 Conclusions High incidence of MR microrganisms High level of antibiotic consumption Vicious circle Recognize the problem and commit ourselves to solve it! Antimicrobial Resistance Prevention and Infection Control: two faces of the same coin
43 To Do List in the near future Join efforts of different institutions Join data to get a better picture Don t just take pictures Create an effective chain of reaction Led by a structure DNH-based That leads, helps, facilitates and educates, in close relation to local stewardship structures Commit Regional Health Authorities Create a system able to finantially reward the merit of improving results and attaining goals Think broad. Put the Alliance to work
44 Armando Brito Sá Filipe Froes Luís Caldeira Luís Marques Lito Luísa Peixe Mafalda Ribeirinho José Artur Paiva PNPRA Steering Group
Summary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More informationAMR epidemiological situation: ECDC update
One Health Network on Antimicrobial Resistance (AMR) AMR epidemiological situation: ECDC update Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI)
More informationEuropean Antibiotic Awareness Day
Initiating a pan-european health campaign - experiences from setting up the European Antibiotic Awareness Day Dr Ülla-Karin Nurm Head of Public Health Development Section, Public Health Capacity and Communication
More informationThe International Collaborative Conference in Clinical Microbiology & Infectious Diseases
The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of
More informationSurveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe
Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe Carl Suetens, ECDC Presented by Håkan Hanberger ecdc.europa.eu Message/Questions from C Suetens to Workshop 7, MIE2009
More informationWhat is the problem? Latest data on antibiotic resistance
European Antibiotic Awareness Day 2009 What is the problem? Latest data on antibiotic resistance Zsuzsanna Jakab, ECDC Director Launch Seminar for EAAD Stockholm, 18 November 2009 Fluoroquinolone-resistant
More informationInitiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector
Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector Niels Frimodt-Møller Professor, MD DMSc Dept. of Clinical Microbiology Hvidovre Hospital, Copenhagen,
More informationAntimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The
Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr Nils Anders Tegnell, Director, The Public Health Agency of Sweden The Global Challenge Antibiotics
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationStratégie et action européennes
Résistance aux antibiotiques : une impasse thérapeutique? Implications nationales et internationales Stratégie et action européennes Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial
More informationThe UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England
The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England Chief Medical Officer - Annual Report 2013 Antimicrobial resistance poses catastrophic
More informationVaccination as a potential strategy to combat Antimicrobial Resistance in the elderly
Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly Wilbur Chen, MD, MS 22-23 March 2017 WHO meeting on Immunization of the Elderly The Problem Increasing consumption
More informationHow is Ireland performing on antibiotic prescribing?
European Antibiotic Awareness Campaign 2016 November Webinar Series on Antibiotic Prescribing How is Ireland performing on antibiotic prescribing? Dr Rob Cunney National Clinical Lead HCAI AMR Clinical
More informationAntimicrobial stewardship as a tool to fight resistance
Havana, septiembre 2018 Antimicrobial stewardship as a tool to fight resistance José Miguel Cisneros Herreros Infectious Diseases Department University Hospital Virgen del Rocío, Sevilla, SPAIN Competing
More informationAntimicrobial Stewardship: efective implementation for improved clinical outcomes
The Challenge of MDR and XDR infections; Barcelona September 2018 Antimicrobial Stewardship: efective implementation for improved clinical outcomes José Miguel Cisneros Herreros Infectious Diseases Department
More informationAntibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011
Antibiotic Resistance Antibiotic Resistance: A Growing Concern Judy Ptak RN MSN Infection Prevention Practitioner Dartmouth-Hitchcock Medical Center Lebanon, NH Occurs when a microorganism fails to respond
More informationRegional Workshop on AMR in South East Asia Penang (Malaysia): March 2018
Regional Workshop on AMR in South East Asia Penang (Malaysia): 26-28 March 2018 Prof : Htay Htay Tin drhtayhtaytin@gmail.com DDG ( Laboratory) National Focal Point for AMR Ministry of Health and Sports
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite
More informationRecommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland
Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the
More informationAntimicrobial stewardship in companion animals: Welcome to a whole new era
Antimicrobial stewardship in companion animals: Welcome to a whole new era John F. Prescott, University Professor Emeritus, Department of Pathobiology, University of Guelph, Guelph, Ontario NG 2W1 prescott@uoguelph.ca
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More information9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS
Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS 1 2 Untoward Effects of Antibiotics Antibiotic resistance Adverse drug events (ADEs) Hypersensitivity/allergy Drug side effects
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013
ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013 What is the European Union? 27 Member States 24 official languages
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationAntimicrobial resistance and antimicrobial consumption in Europe
Antimicrobial resistance and antimicrobial consumption in Europe Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Programme Vilnius, 28 November
More information1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection
Surveillance, Outbreaks, and Reportable Diseases, Oh My! Assisted Living Facility, Nursing Home and Surveyor Infection Prevention Training February 2015 A.C. Burke, MA, CIC Health Care-Associated Infection
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More information03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline
Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?
More informationAntimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services
Antimicrobial Stewardship/Statewide Antibiogram Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda CMS and JCAHO
More informationAntibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship
Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship J. Hudson Garrett Jr., PhD, MSN, MPH, FNP-BC, PLNC, CDONA, IP-BC, GDCN, CDP, CADDCT, CALN, VA-BC, AS-BC,
More informationBACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)
BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016) VA Palo Alto Health Care System April 14, 2017 Trisha Nakasone, PharmD, Pharmacy Service Russell Ryono, PharmD, Public Health Surveillance
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationUPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM
UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union November 2012 Highlights on antibiotic consumption Antibiotic use is one of the main factors responsible for the development and
More informationTwo (II) Upon signature
Page 1/5 SCREENING FOR ANTIBIOTIC RESISTANT ORGANISMS (AROS) IN ACUTE CARE AND LONG TERM CARE Infection Prevention and Control IPC 050 Issuing Authority (sign & date) Office of Administrative Responsibility
More informationAntibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University
Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine Mike Apley Kansas State University Changes in Food Animal Antibiotic Use How the uses of antibiotics in
More informationLEARNING OBJECTIVES ANTIMICROBIAL USES AND ABUSES INFECTIOUS DISEASE SCARES
LEARNING OBJECTIVES ANTIMICROBIAL USES AND ABUSES Goodbye to the Antibiotic Era? Glenn D. Bedsole, MD, FACP Infectious Disease Consultant 1. Be able to list 6 examples of resistant bacteria that present
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationWorkplan on Antibiotic Usage Management
IMPACT Forum: Antibiotic Guideline in Perspective Workplan on Antibiotic Usage Management Dr. Raymond Yung Consultant Microbiologist PYNEH 20 April 2002 May 2002 Dr. Raymond Yung 1 Objective 1. Heighten
More informationRCH antibiotic susceptibility data
RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological
More informationNew Drugs for Bad Bugs- Statewide Antibiogram
New Drugs for Bad Bugs- Statewide Antibiogram Felicia Matthews, Pharm.D., BCPS Senior Consultant, Pharmacy Specialty BE MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda
More informationPrevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices
Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationEnglish Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR)
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Berit Muller-Pebody HCAI & AMR Department, Centre for Infectious Disease Surveillance and Control Chief Medical Officer
More informationPublic Health Response to Emerging Resistance
National Center for Emerging and Zoonotic Infectious Diseases Public Health Response to Emerging Resistance Alex Kallen, MD, MPH, FACP Lead Antimicrobial Resistance and Emerging Pathogens Team Prevention
More information2016/LSIF/FOR/007 Improving Antimicrobial Use and Awareness in Korea
2016/LSIF/FOR/007 Improving Antimicrobial Use and Awareness in Korea Submitted by: Asia Pacific Foundation for Infectious Diseases Policy Forum on Strengthening Surveillance and Laboratory Capacity to
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationWhat s next in the antibiotic pipeline?
What s next in the antibiotic pipeline? Jennifer Tieu, Pharm.D., BCPS Clinical Pearls OSHP Spring Meeting Mercy Hospital April 13, 2018 Objective 2 Describe the drug class and mechanism of action of antibiotics
More informationHospital Acquired Infections in the Era of Antimicrobial Resistance
Hospital Acquired Infections in the Era of Antimicrobial Resistance Datuk Dr Christopher KC Lee Infectious Diseases Unit Department of Medicine Sungai Buloh Hospital Patient Story 23 Year old female admitted
More informationThe threat of multidrug-resistant microorganisms and how to deal with it in Europe
The threat of multidrug-resistant microorganisms and how to deal with it in Europe Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
More informationAntimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report
Antimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationPRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse
More informationMultidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?
Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Roberta B. Carey, PhD Centers for Disease Control and Prevention Division of Healthcare Quality Promotion Why worry? MDROs Clinical
More informationThese life-saving drugs have been a boon to medical care and benefited hundreds of million patients around the globe.
SINCE Sir Alexander Fleming, a Scottish biologist, pharmacologist and botanist (a 1945 Nobel laureate), first discovered penicillin in 1923, hundreds of more potent wider spectrum antibiotics have been
More informationAntimicrobial Stewardship:
Antimicrobial Stewardship: Inpatient and Outpatient Elements Angela Perhac, PharmD afperhac@carilionclinic.org Disclosure I have no relevant finances to disclose. Objectives Review the core elements of
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22 December 2005 COM (2005) 0684 REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION
More informationHospital ID: 831. Bourguiba Hospital. Tertiary hospital
Global Point Prevalence Survey of Antimicrobial Consumption and Resistance in hospitals worldwide Hospital ID: 831 Habib Bourguiba Hospital Tertiary hospital Tunisia Point Prevalence Survey Habib 2017
More informationBacterial infections complicating cirrhosis
PHC www.aphc.info Bacterial infections complicating cirrhosis P. Angeli, Dept. of Medicine, Unit of Internal Medicine and Hepatology (), University of Padova (Italy) pangeli@unipd.it Agenda Epidemiology
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXVII NUMBER 6 July 2012 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine B. Dowell SM, MLS (ASCP); Sarah K. Parker, MD; James K. Todd, MD Each year the Children s Hospital Colorado
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationINCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS
INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS 1 Research Associate, Drug Utilisation Research Unit, Nelson Mandela University 2 Human Sciences Research Council,
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More information9.5 Antimicrobial Resistance
9.5 Antimicrobial Resistance Key Points In 215, there was a slight reduction in coverage of the Irish population by EARS-Net versus 214, from 1% to 97% There were 2,697 reports of invasive Escherichia
More informationProf. Otto Cars. We are overconsuming a global resource. It is a collective responsibility by governments, supranational organisatons
What are the consequences of rising antibiotic resistance for Sweden? Prof. Otto Cars Chairman The Swedish Strategic programme against antibiotic resistance (Strama) We are overconsuming a global resource
More informationWHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health
New WHO report provides the most comprehensive picture of antibiotic resistance to date, with data from 114 countries 30 APRIL 2014 GENEVA - A new report by WHO its first to look at antimicrobial resistance,
More informationNational Surveillance of Antimicrobial Resistance
National Surveillance of Antimicrobial Resistance Report to Ministry of Health by Sri Lanka College of Microbiologists SLCM ARSP & NLBSA Technical Committees December 2014 National Surveillance of Antimicrobial
More informationANTIMICROBIAL STEWARDSHIP: ADVANCING PATIENT CARE BY IMPROVING MEDICATION USE
ANTIMICROBIAL STEWARDSHIP: ADVANCING PATIENT CARE BY IMPROVING MEDICATION USE ANTHONY M. CASAPAO, PHARM.D. ASSISTANT PROFESSOR OF PHARMACY PRACTICE HUSSON UNIVERSITY SCHOOL OF PHARMACY CLINICAL INFECTIOUS
More informationESAC s Surveillance by Point Prevalence Measurements. by author
ESAC s Surveillance by Point Prevalence Measurements Herman Goossens, MD, PhD ESAC Co-ordinator VAXINFECTIO, Laboratory of Medical Microbiology University of Antwerp, Belgium Outline Background Point Prevalence
More informationAberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015
Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New
More informationAntimicrobial Stewardship Program: Local Experience
Antimicrobial Stewardship Program: Local Experience Dr. WU Tak Chiu Associate Consultant Division of Infectious Diseases Department of Medicine Queen Elizabeth Hospital 18th January 2011 QUEEN ELIZABETH
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationImpact of NHS England Quality Indicators on Antimicrobial Resistance. Professor Alan Johnson National Infection Service Public Health England
Impact of NHS England Quality Indicators on Antimicrobial Resistance Professor Alan Johnson National Infection Service Public Health England A Risk Assessment of Antibiotic Pan-Drug Resistance in the UK:
More informationECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials
ECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials P.-A. Belœil (EFSA) and D. Monnet (ECDC) One Health Network on Antimicrobial Resistance
More informationReport on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli"
Preserving the Power of Antibiotics Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli" Held on Thursday, September 30, 2004 in Boston, MA Preceding
More informationESCMID Online Lecture Library. by author
System for early warning and national surveillance of antimicrobial resistance! Gunnar Kahlmeter Clinical microbiology Växjö, Sweden Early warning for antimicrobial resistance Local level (laboratory uptake
More informationThe Rise of Antibiotic Resistance: Is It Too Late?
The Rise of Antibiotic Resistance: Is It Too Late? Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine None DISCLOSURES THE PROBLEM Antibiotic resistance is one of the
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More information9.4 Antimicrobial Resistance
9.4 Antimicrobial Resistance a) Key Pathogens causing Bloodstream Infections 2016 Summary Estimated 99% coverage of the Irish population versus 97% in 2015 There were 3,057 reports of invasive E. coli
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More informationAntimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013
Antimicrobial Resistance Surveillance from sentinel public s, South Africa, 213 Authors: Olga Perovic 1,2, Melony Fortuin-de Smidt 1, and Verushka Chetty 1 1 National Institute for Communicable Diseases
More informationAntimicrobial Use and Resistance in Australia
Antimicrobial Use and Resistance in Australia John Turnidge Senior Medical Advisor, ACSQHC Funding from July 2013 to June 2016 to establish antimicrobial resistance surveillance in Australia The National
More informationCollecting and Interpreting Stewardship Data: Breakout Session
Collecting and Interpreting Stewardship Data: Breakout Session Michael S. Calderwood, MD, MPH Regional Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center March 20, 2019 None Disclosures Outline
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationAntibiotic Stewardship in Human Health- Progress and Opportunities
National Center for Emerging and Zoonotic Infectious Diseases Antibiotic Stewardship in Human Health- Progress and Opportunities CAPT Lauri A. Hicks, D.O. Director, Office of Antibiotic Stewardship Division
More informationMike Apley Kansas State University
Mike Apley Kansas State University 2003 - Daptomycin cyclic lipopeptides 2000 - Linezolid - oxazolidinones 1985 Imipenem - carbapenems 1978 - Norfloxacin - fluoroquinolones 1970 Cephalexin - cephalosporins
More informationARCH-Vet. Summary 2013
Federal Department of Home Affairs FDHA FSVO ARCH-Vet Report on sales of antibiotics in veterinary medicine and antibiotic resistance monitoring of livestock in Switzerland Summary 2013 Published by Federal
More informationANTIMICROBIAL STEWARDSHIP IN SCOTLAND. Key achievements of the Scottish Antimicrobial Prescribing Group
ANTIMICROBIAL STEWARDSHIP IN SCOTLAND Key achievements of the Scottish Antimicrobial Prescribing Group Dr Jacqueline Sneddon Project Lead Scottish Antimicrobial Prescribing Group Overview of talk ScotMARAP
More informationAntimicrobial Stewardship. Where are we now and where do we need to go?
Safe Patient Care Bugs and Drugs The ongoing challenge of MDROs and AMR 2017 @SPC2016Cork Antimicrobial Stewardship. Where are we now and where do we need to go? Frank O Riordan Antimicrobial pharmacist,
More informationAntimicrobial Stewardship in Scotland
Antimicrobial Stewardship in Scotland UKCPA/FIS Scientific Meeting 18 th November 2010 Triumphs and Unintended Consequences Dr Jacqueline Sneddon Project Lead for Scottish Antimicrobial Prescribing Group
More informationUNDERSTANDING SOUTH AFRICA'S CONSUMPTION OF ANTIMICROBIALS
UNDERSTANDING SOUTH AFRICA'S CONSUMPTION OF ANTIMICROBIALS Pharmacy Society of South Africa Conference 2018 Ruth Lancaster Contents 1. Background AMR National Strategic Plan 2. Sources of antimicrobial
More informationNew Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs
New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs Patrick R. Murray, PhD Senior Director, WW Scientific Affairs 2017 BD. BD, the BD Logo and all other trademarks
More informationSECOND REPORT FROM THE COMMISSION TO THE COUNCIL
SECOND REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION (2002/77/EC) ON THE PRUDENT USE OF ANTIMICROBIAL AGENTS IN HUMAN
More informationEpidemiology and Economics of Antibiotic Resistance
Epidemiology and Economics of Antibiotic Resistance Eili Y. Klein February 17, 2016 Health Watch USA Meeting I. The burden of antibiotic resistance is a growing global threat, but hard numbers are lacking
More informationAntibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE
Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationAntimicrobial resistance (EARS-Net)
SURVEILLANCE REPORT Annual Epidemiological Report for 2014 Antimicrobial resistance (EARS-Net) Key facts Over the last four years (2011 to 2014), the percentages of Klebsiella pneumoniae resistant to fluoroquinolones,
More informationPreventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal
Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal 07.03.01 2009 Methicillin Resistant Staphlococcus aureus (MRSA) About 3-8% of the population at large is a carrier
More informationAntibiotic Resistance in India
Antibiotic Resistance in India Sumanth Gandra MD, MPH Center for Disease Dynamics, Economics & Policy July 5, 2017 AMR Cross Council Initiative Challenges and Opportunities Workshop, Heathrow Disclaimer/Disclosures
More informationSolution Title: Antibiotic Stewardship: A Journey Toward the Triple Aim
Solution Title: Antibiotic Stewardship: A Journey Toward the Triple Aim Program/Project Description, including Goals What was the problem to be solved? How was it identified? What baseline data existed?
More information